Chris Aiken, MD

Dr. Aiken is the Editor in Chief of The Carlat Psychiatry Report; director of the Mood Treatment Center in North Carolina, where he maintains a private practice combining medication and therapy along with evidence-based complementary and alternative treatments; and Assistant Professor NYU Langone Department of Psychiatry. He has worked as a research assistant at the NIMH and a sub-investigator on clinical trials, and conducts research on a shoestring budget out of his private practice. Follow him on Twitter and find him on LinkedIn.

Auvelity A Fast Acting Antidepressant

February 5, 2024

Chris Aiken, MD and Kellie Newsome, PMHNP

Auvelity, a new rapid acting medication for depression, is a branded combination of two generic drugs. We look at how it works and the clinical trials, including new data in treatment resistant depression

Clinical Update

Six Recent Disappointments in Psychiatric Research

February 1, 2024

Chris Aiken, MD

Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Dr. Aiken has no financial relationships with companies related to this material.

Find out where standard therapies like cariprazine and esketamine have failed in recent trials, along with novel medications like minocycline, zuranolone, pimavanserin, and NAC.

Mood Stabilizers in Older Adults

January 29, 2024

Chris Aiken, MD and Kellie Newsome, PMHNP

How to choose a mood stabilizer in older adults.

Bipolar in Older Adults

January 22, 2024

Chris Aiken, MD and Kellie Newsome, PMHNP

Mania is different in the elderly, and today we look at the medical causes to watch out for.

A New Form of Lithium

January 8, 2024

Chris Aiken, MD and Kellie Newsome, PMHNP

A new formulation of lithium is being developed. Plus updates on lithium in younger, older, and peripartum patients.

Lithium: 12 Updates from 2023

January 1, 2024

Chris Aiken, MD and Kellie Newsome, PMHNP

A year of research on lithium, including updates on its efficacy, renal risks, tremor, and a controlled trial of instant vs. extended release.

Clinical Update

Negative Symptoms of Schizophrenia

January 1, 2024

Chris Aiken, MD and Paul Riordan, MD.

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Paul Riordan, MD. Assistant Consulting Professor of Psychiatry, Duke University, Durham, NC.

The authors have no financial relationships with companies related to this material.

Negative symptoms are the primary cause of disability in schizophrenia, and we identify a few antipsychotics and a few add-on therapies that can help.